We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Benjamin Besse

Benjamin Besse MD

Head, Thoracic Cancer Unit, Department of Medicine, Institut Gustave Roussy, Villejuif, France

Recent Contributions to PracticeUpdate:

  1. Hyperprogressive Disease in Lung Cancer Patients Treated With Immunotherapy
  2. First- vs Next-Generation TKIs for NSCLC With Driver Mutations
  3. ESMO 2018: Atezolizumab With Chemotherapy in First-line Treatment of Non-squamous NSCLC

Most Read This Week

Recently Updated